Why Traditional Medications Don’t Work for Everyone
After months of struggling with anxiety, you finally made the appointment. Your doctor listened, nodded knowingly, and reached for the prescription pad. Perhaps it was a benzodiazepine like Xanax or Klonopin. Maybe an SSRI like Prozac or Zoloft. “This should help,” they said. “Give it a few weeks.”
For many people, this is where the story takes a positive turn. But for a significant number of others, it’s just the beginning of a frustrating journey through side effects, dependency concerns, and the disappointing realization that these medications don’t always deliver the relief promised.
If you’re in that second group, this post is for you. You’re not treatment-resistant, and you’re not a lost cause. The issue might not be you at all – it might be the treatment approach itself.
The Standard Treatment Playbook
When it comes to anxiety disorders, conventional medicine relies primarily on two categories of pharmaceuticals: benzodiazepines for short-term relief and antidepressants (primarily SSRIs) for long-term management. Let’s look at how each works – and where they can fall short.
Benzodiazepines like diazepam, lorazepam, and alprazolam work by enhancing GABA neurotransmission in the brain. GABA is your brain’s primary “brake pedal” – it slows down neuronal activity and produces calming effects¹. Benzodiazepines essentially make that brake pedal more sensitive, quickly reducing anxiety symptoms.
They’re effective – sometimes remarkably so. But there’s a catch. Actually, several catches.
First, they’re intended for short-term use only. Yet many people find themselves taking them for months or years because discontinuing them triggers withdrawal symptoms that can be severe. The medical literature increasingly recognizes benzodiazepine dependence as a significant clinical problem².
Second, they come with cognitive side effects. Memory problems, difficulty concentrating, drowsiness, and impaired coordination are common. If you’ve ever felt mentally “foggy” on these medications, you’re experiencing a known pharmacological effect, not an unusual reaction.
SSRIs and other antidepressants take a different approach. They work by increasing serotonin availability in the brain, based on the theory that anxiety and depression involve serotonin dysfunction. Unlike benzodiazepines, they’re not addictive and don’t cause the same dependency issues.
But they have their own limitations. They typically take 4-6 weeks to show effects, meaning you wait over a month to know if they’ll even work for you. When they do work, it’s often partial relief rather than complete resolution. And side effects – sexual dysfunction, weight gain, emotional blunting, and gastrointestinal issues – cause many people to discontinue treatment³.
The Polypharmacy Problem
Here’s where things get complicated. Anxiety rarely appears in isolation. As we discussed in our previous post, it frequently coexists with depression, sleep disorders, and chronic pain. Western medicine’s typical response? Separate medications for each condition.
One pill for anxiety. Another for depression. A third for sleep. Perhaps a fourth for pain. Before long, you’re managing a complex medication regimen, each drug with its own side effects and potential interactions⁴. This approach – called polypharmacy – isn’t necessarily wrong, but it can become overwhelming and create its own problems.
Contrast this with herbal medicine traditions, where a single plant (or combination of plants) often addresses multiple related conditions simultaneously. Cannabis sativa, for instance, has been traditionally used to address anxiety, sleep disturbances, pain, and mood issues together – not because it’s a miracle cure, but because these conditions share underlying physiological mechanisms⁴.
When the Treatment Becomes the Problem
Sarah’s story (not her real name) is typical of many we hear. Prescribed clonazepam for panic attacks, she found it worked beautifully at first. But after six months, she needed higher doses for the same effect. When she tried to stop, withdrawal symptoms were so severe – intense anxiety, insomnia, sweating, tremors – that she couldn’t function. She felt trapped in a cycle where the medication meant to help had become a problem itself.
Her doctor’s response? “We’ll taper you very slowly.” The tapering schedule stretched over 12 months and required immense determination. During this process, she discovered that CBD-rich cannabis could help manage the withdrawal anxiety, making the taper more tolerable⁵.
Research increasingly supports experiences like Sarah’s. A retrospective study found that 30% of patients discontinued benzodiazepine use within two months of starting medical cannabis, and 45% had discontinued by six months⁶. These weren’t people switching addictions – they were finding an alternative that worked without the dependency issues.
The Effectiveness Gap
Here’s a reality rarely discussed openly: pharmaceutical anxiolytics simply don’t work for everyone. Even when they do work, the response is often incomplete. You feel… better. Not good. Not like yourself. Just… less anxious, but also less everything else.
Studies show that up to 40% of people don’t respond adequately to first-line SSRI treatment for anxiety⁷. That’s not a small minority – it’s nearly half. And of those who do respond, many experience only partial symptom reduction.
This isn’t a failure of the patients. It’s a limitation of a treatment paradigm that views anxiety as simply a “chemical imbalance” requiring chemical correction. The reality is far more nuanced, involving complex interactions between neurotransmitter systems, inflammatory processes, stress hormones, and even gut health⁸.
The Hidden Cost of Side Effects
Beyond the direct physical side effects lies something more subtle but equally impactful: the emotional cost of feeling chemically altered. Many people on anxiety medications describe feeling “flattened” or “dampened.” Yes, the anxiety is reduced, but so is joy, excitement, and emotional connection.
Sexual dysfunction from SSRIs affects an estimated 40-65% of people taking them⁹. For many, this creates a cruel choice: manage your anxiety or maintain your intimate relationships. Why should you have to choose?
A Different Approach
What if there were compounds that work with your body’s own regulatory systems rather than overriding them? What if you could address anxiety without the risk of dependency, without waiting weeks to see if something works, without accepting significant side effects as inevitable?
This isn’t wishful thinking. Your body already has a sophisticated system for regulating anxiety, stress response, and emotional balance – the endocannabinoid system. For most people, this system works well. But chronic stress, poor diet, lack of sleep, and other modern lifestyle factors can throw it off balance¹⁰.
Supporting this system rather than bypassing it entirely represents a fundamentally different therapeutic approach – one that’s gaining scientific validation while avoiding many of the pitfalls of conventional anxiolytics.
You Have More Options
If traditional anxiety medications have disappointed you, it doesn’t mean you’re out of options. It means the right option for your unique biochemistry might lie outside the standard prescription pad.
In our next post, we’ll explore CBD – the non-intoxicating compound from cannabis that’s showing remarkable promise for anxiety without the “high,” the dependency, or many of the side effects associated with conventional treatments.
Your journey with anxiety isn’t over just because one approach didn’t work. Sometimes the path to feeling like yourself again requires stepping off the well-worn trail.
References:
- Fuentes D, Ray SD, Holstege CP. Anxiolytics. In: Wexler, editor. Encyclopedia of Toxicology. Third ed. Elsevier; 2014. p. 280–6
- Ho TT, Gupta SV, Sanchez-Valle A. Prolonged clonazepam-induced withdrawal symptoms in an NAT2 ultraslow acetylator. Pharmacogenomics. 2019;20(02):69–73. https://doi.org/10.2217/pgs-2018-0145
- Davis CP. Anti-Anxiety Drugs (Anxiolytics) Side Effects, List of Names. MedicineNet. https://www.medicinenet.com/anxiolytics_for_anxiety_drug_class/article.htm
- Arrow BA, Hunkeler EM, Blasey CM, et al. Comorbid depression, chronic pain and disability in primary care. Psychosom Med. 2006;68:262–8. https://pubmed.ncbi.nlm.nih.gov/16554380/
- Purcell C, Davis A, Moolman N, Taylor SM. Reduction of benzodiazepine use in patients prescribed medical cannabis. Cannabis Cannabinoid Res. 2019;4(3):214–8. https://www.liebertpub.com/doi/10.1089/can.2019.0020
- Purcell C, Davis A, Moolman N, Taylor SM. Reduction of benzodiazepine use in patients prescribed medical cannabis. Cannabis Cannabinoid Res. 2019;4(3):214–8. https://www.liebertpub.com/doi/10.1089/can.2019.0020
- Bandelow B, et al. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93-107. https://pmc.ncbi.nlm.nih.gov/articles/PMC5573566/
- Salim S, Chugh G, Asghar M. Chapter One – Inflammation in anxiety. Adv Protein Chem Struct Biol. 2012;88:1–25. https://pubmed.ncbi.nlm.nih.gov/22814704/
- Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29:259-66. https://pubmed.ncbi.nlm.nih.gov/19440080/
- Hill MN, Patel S, Campolongo P, et al. Functional interactions between stress and the endocannabinoid system. J Neurosci. 2010;30(45):14980–6. https://pubmed.ncbi.nlm.nih.gov/21068301/
